1.6000
-0.0400
(-2.44%)
At close: January 30 at 4:00:01 PM EST
1.5600
-0.04
(-2.50%)
After hours: January 30 at 5:15:29 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,430.0000
-18,292.0000
-44,038.0000
-62,932.0000
-50,818.0000
Investing Cash Flow
16,431.0000
-5,758.0000
18,002.0000
58,952.0000
-52,431.0000
Financing Cash Flow
-4,718.0000
143.0000
707.0000
6,808.0000
118,876.0000
End Cash Position
2,915.0000
20,752.0000
44,579.0000
69,724.0000
66,841.0000
Capital Expenditure
-148.0000
-160.0000
-133.0000
-180.0000
-52.0000
Issuance of Capital Stock
608.0000
--
608.0000
--
117,628.0000
Repayment of Debt
--
-6.0000
-49.0000
--
-34.0000
Free Cash Flow
-30,578.0000
-18,452.0000
-44,171.0000
-63,112.0000
-50,870.0000
12/31/2020 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PMVP PMV Pharmaceuticals, Inc.
1.4400
+0.70%
ABOS Acumen Pharmaceuticals, Inc.
1.5600
-0.64%
GANX Gain Therapeutics, Inc.
2.2000
+5.26%
IMUX Immunic, Inc.
1.0200
+3.03%
SEER Seer, Inc.
2.3600
+1.29%
SABS SAB Biotherapeutics, Inc.
2.1700
-2.69%
AKTX Akari Therapeutics, Plc
1.3500
0.00%
MREO Mereo BioPharma Group plc
2.9300
0.00%
TSBX Turnstone Biologics Corp.
0.4840
-0.21%
MNOV MediciNova, Inc.
2.0500
+1.49%